Impaired immune and acute-phase responses in interleukin-6-deficient mice
Abstract
Interleukin-6 (IL-6) is a multifunctional cytokine that regulates various aspects of the immune response, acute-phase reaction and haematopoiesis (for reviews see refs 1, 2). In vitro, leukaemia inhibitory factor, oncostatin M, ciliary neurotrophic factor and interleukin-11 display overlapping activities with IL-6. This functional redundancy may be explained by the interactions of specific binding receptors with a common signal-transducing receptor (gp130) (for reviews see refs 3, 4). To elucidate the unique function of IL-6 in vivo, we have disrupted the IL-6 gene by homologous recombination. IL-6-deficient mice develop normally. They fail to control efficiently vaccinia virus and infection with Listeria monocytogenes, a facultative intracellular bacterium. The T-cell-dependent antibody response against vesicular stomatitis virus is impaired. Further, the inflammatory acute-phase response after tissue damage or infection is severely compromised, whereas it is only moderately affected after challenge with lipopolysaccharide. We conclude that IL-6 production induced by injury or infection is an important in vivo SOS signal which coordinates activities of liver cells, macrophages and lymphocytes.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
A certain amount of IL-6 is required for efficient immune defense and liver regeneration.
“On the other hand, a certain amount of IL-6 is required for efficient immune defense (Kopf et al., 1994) and liver regeneration (Cressman et al., 1996; Sakamoto et al., 1999; Zimmers et al., 2003).”
From Model Based Targeting of IL-6-Induced Inflammatory Responses in Cultured Primary Hepatocytes to Improve Application of the JAK Inhibitor Ruxolitinib (2017) · cites this paper as Kopf et al., 1994
IL-6 is a critical inducer of the acute phase response in the liver.
“IL-6 is a critical inducer of the acute phase (AP) response in the liver, 11”
From Interleukin 6 Is Important for Survival After Partial Hepatectomy in Mice (2003) · cites this paper as [11]
IL-6 transgenic mice show severe plasmacytosis with hypergammaglobulinemia, while IL-6-deficient mice are defective in immunoglobulin production.
“IL-6 transgenic mice show severe plasmacytosis with hypergammaglobulinemia (147), while IL-6-deficient mice are defective in immunoglobulin production (148, 149).”
From IL-6 in inflammation, autoimmunity and cancer (2021) · cites this paper as [148]
Cited by
Sorted by citations
Ivanov, I. I., McKenzie, B. S., Zhou, L., Tadokoro, C. E., Lepelley, A., Lafaille, J. J., Cua, D. J., & Littman, D. R. (2006) · Cell · doi:10.1016/j.cell.2006.07.035 · Cited by 5,145 · see citing works
The pro- and anti-inflammatory properties of the cytokine interleukin-6
Scheller, J., Chalaris, A., Schmidt-Arras, D., & Rose-John, S. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2011.01.034 · Cited by 3,212 · see citing works
Targeting the IL-6/JAK/STAT3 signalling axis in cancer
Johnson, D. E., O'Keefe, R. A., & Grandis, J. R. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2018.8 · Cited by 3,110 · see citing works
IL-6 as a keystone cytokine in health and disease
Hunter, C. A., & Jones, S. A. (2015) · Nature Immunology · doi:10.1038/ni.3153 · Cited by 2,511 · see citing works
Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine
von Freeden-Jeffry, U., Vieira, P., Lucian, L., McNeil, T., Burdach, S. E. G., & Murray, R. (1995) · Journal of Experimental Medicine · doi:10.1084/jem.181.4.1519 · Cited by 1,648 · see citing works
IL‐6: Regulator of Treg/Th17 balance
Kimura, A., & Kishimoto, T. (2010) · European Journal of Immunology · doi:10.1002/eji.201040391 · Cited by 1,605 · see citing works
Self-citationGp130 and the interleukin-6 family of cytokines.
Taga, T., & Kishimoto, T. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.797 · Cited by 1,603 · see citing works
Self-citationXing, Z., Gauldie, J., Cox, G., Baumann, H., Jordana, M., Lei, X.-F., & Achong, M. K. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1368 · Cited by 1,578 · see citing works
“The generation of mice deficient in IL-6 gene (C57Bl/6 3 129Sv) and normal control littermates was described elsewhere (8).”
BackgroundMethodResultInfluentialSelf-citationKlinman, D. M., Yi, A., Beaucage, S. L., Conover, J., & KRIEG, A. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.7.2879 · Cited by 1,459 · see citing works
Liver Failure and Defective Hepatocyte Regeneration in Interleukin-6-Deficient Mice
Cressman, D. E., Greenbaum, L. E., DeAngelis, R. A., Ciliberto, G., Furth, E. E., Poli, V., & Taub, R. (1996) · Science · doi:10.1126/science.274.5291.1379 · Cited by 1,536 · see citing works
Interleukin-6 and chronic inflammation
Gabay, C. (2006) · Arthritis Research & Therapy · doi:10.1186/ar1917 · Cited by 1,468 · see citing works
“In chronic diseases, typically exemplified by immune stressors such as chronic intracellular infections and tumours, IL-6 not only serves as an inducer of acute phase reactions but also is an important player in eliciting cellular immune responses to affected cells and mucosal humoral responses directed against reinfe…”
BackgroundIL-6 in inflammation, autoimmunity and cancer
Hirano, T. (2021) · International Immunology · doi:10.1093/intimm/dxaa078 · Cited by 1,453 · see citing works
“IL-6 transgenic mice show severe plasmacytosis with hypergammaglobulinemia (147), while IL-6-deficient mice are defective in immunoglobulin production (148, 149).”
BackgroundPlasma cell differentiation requires the transcription factor XBP-1
Reimold, A., Iwakoshi, N., Manis, J., Vallabhajosyula, P., Szomolanyi-Tsuda, E., Gravallese, E., Friend, D., Grusby, M., Alt, F., & Glimcher, L. (2001) · Nature · doi:10.1038/35085509 · Cited by 1,371 · see citing works
Imai, Y., Kuba, K., Neely, G. G., Yaghubian-Malhami, R., Perkmann, T., van Loo, G., Ermolaeva, M., Veldhuizen, R., Leung, Y. H. C., Wang, H., et al. (2008) · Cell · doi:10.1016/j.cell.2008.02.043 · Cited by 1,356 · see citing works
“To test if IL-6 is indeed involved in the pathogenesis of ALI, we studied il-6 / mice (Kopf et al., 1994).”
BackgroundSelf-citationRegulation of the Hypothalamic-Pituitary-Adrenal Axis by Cytokines: Actions and Mechanisms of Action
TURNBULL, A. V., & RIVIER, C. L. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.1.1 · Cited by 1,297 · see citing works
Hirano, T., Ishihara, K., & Hibi, M. (2000) · Oncogene · doi:10.1038/sj.onc.1203551 · Cited by 1,187 · see citing works
“…maturation (Betz et al., 1998; Cressman et al., 1996; Escary et al., 1993; Hilbert et al., 1995a; Hirota et al., 1999; Kamiya et al., 1999; Kopf et al., 1994, 1998; Kumanogoh et al., 1997; Masu et al., 1993; Ohtani et al., 2000; Poli et al., 1994; Ramsay et al., 1994; Romani et al.,…”
BackgroundNeutrophil kinetics in health and disease
Summers, C., Rankin, S. M., Condliffe, A. M., Singh, N., Peters, A. M., & Chilvers, E. R. (2010) · Trends in Immunology · doi:10.1016/j.it.2010.05.006 · Cited by 1,237 · see citing works
Interleukin-6-deficient mice develop mature-onset obesity
Wallenius, V., Wallenius, K., Ahrén, B., Rudling, M., Carlsten, H., Dickson, S. L., Ohlsson, C., & Jansson, J.-O. (2002) · Nature Medicine · doi:10.1038/nm0102-75 · Cited by 1,213 · see citing works
“The immune-regulating and acute phase–inducing cytokine interleukin-6 (IL-6”
BackgroundRole of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment.
Romano, M., Sironi, M., Toniatti, C., Polentarutti, N., Fruscella, P., Ghezzi, P., Faggioni, R., Luini, W., van Hinsbergh, V., Sozzani, S., et al. (1997) · Immunity · doi:10.1016/s1074-7613(00)80334-9 · Cited by 1,181 · see citing works
Serum amyloid A, the major vertebrate acute‐phase reactant
Uhlar, C., & Whitehead, A. S. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00657.x · Cited by 1,101 · see citing works
The Pathophysiologic Roles of Interleukin-6 in Human Disease
Papanicolaou, D. A., Wilder, R. L., Manolagas, S. C., & Chrousos, G. P. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-128-2-199801150-00009 · Cited by 1,146 · see citing works
Recent insights into targeting the IL-6 cytokine family in inflammatory diseases and cancer
Jones, S. A., & Jenkins, B. J. (2018) · Nature Reviews Immunology · doi:10.1038/s41577-018-0066-7 · Cited by 1,102 · see citing works
Interleukin-6: from basic science to medicine--40 years in immunology.
Kishimoto, T. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115806 · Cited by 1,083 · see citing works
Self-citationCytokines and the hepatic acute phase response
Moshage, H. (1997) · Journal of Pathology · doi:10.1002/(sici)1096-9896(199703)181:3 · Cited by 1,035 · see citing works
The Neutrophil's Role During Health and Disease.
Liew, P., & Kubes, P. (2019) · Physiological Reviews · doi:10.1152/physrev.00012.2018 · Cited by 1,032 · see citing works
IL-6 switches the differentiation of monocytes from dendritic cells to macrophages
Chomarat, P., Banchereau, J., Davoust, J. M., & Palucka, K. (2000) · Nature Immunology · doi:10.1038/82763 · Cited by 906 · see citing works
“The role of IL-6 in the generation of human macrophages provides an explanation for the altered clearance of pathogens such as Listeria or Mycobacterium in mice whose Il6 and Nfil6 genes have been inactivate”
BackgroundEndometrial receptivity markers, the journey to successful embryo implantation.
Achache, H., & Revel, A. (2006) · Human Reproduction Update · doi:10.1093/humupd/dml004 · Cited by 952 · see citing works
“Nevertheless, the development of the blastocyst is compromised (Kopf et al., 1994; Salamonsen et al., 2000).”
BackgroundThe endocrine function of adipose tissue: an update
Ronti, T., Lupattelli, G., & Mannarino, E. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02474.x · Cited by 906 · see citing works
Hematopoietic stem cell: self‐renewal versus differentiation
Seita, J., & Weissman, I. L. (2010) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.86 · Cited by 925 · see citing works
Carey, A. L., Steinberg, G. R., Macaulay, S. L., Thomas, W. G., Holmes, A. G., Ramm, G., Prelovsek, O., Hohnen-Behrens, C., Watt, M. J., James, D. E., et al. (2006) · Diabetes · doi:10.2337/db05-1404 · Cited by 898 · see citing works
“(29) and littermate control mice (wild type) were used in these experiments.”
MethodInterleukins, from 1 to 37, and interferon-γ: Receptors, functions, and roles in diseases
Akdiş, M., Bürgler, S., Crameri, R., Eiwegger, T., Fujita, H., Alcaide, E. G., Klunker, S., Meyer, N., O’Mahony, L., Palomares, Ó., et al. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.11.050 · Cited by 780 · see citing works
Sanos, S. L., Bui, V. L., Mortha, A., Oberle, K., Heners, C., Johner, C., & Diefenbach, A. (2008) · Nature Immunology · doi:10.1038/ni.1684 · Cited by 843 · see citing works
IL-6 pathway in the liver: From physiopathology to therapy
Schmidt-Arras, D., & Rose-John, S. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.02.004 · Cited by 881 · see citing works
Iwakoshi, N. N., Lee, A.-H., Vallabhajosyula, P., Otipoby, K. L., Rajewsky, K., & Glimcher, L. H. (2003) · Nature Immunology · doi:10.1038/ni907 · Cited by 880 · see citing works
“The existence of an XBP-1–IL-6 autoregulatory loop may explain the observation that IL-6–deficient mice show defects similar to those of XBP-1–deficient mice outside the immune system, with impaired production of acute-phase reactants and defects in hepatocyte growt”
BackgroundInterleukin-6 Is an Essential Regulator of Satellite Cell-Mediated Skeletal Muscle Hypertrophy
Serrano, A. L., Baeza-Raja, B., Perdiguero, E., Jardí, M., & Muñoz-Cánoves, P. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.11.011 · Cited by 873 · see citing works
“…3 C57BL/6 background (WT) and generated by heterozygous mating of mice carrying a targeted disruption in which the second exon in the IL-6 gene was replaced by a neo r cassette (Kopf et al., 1994), were generously provided by A. Bernad (Centro Nacional de Investiga-ciones Cardiovasculares, Madrid).”
MethodThe microbiota regulates type 2 immunity through RORγt <sup>+</sup> T cells
Ohnmacht, C., Park, J.-H., Cording, S., Wing, J. B., Atarashi, K., Obata, Y., Gaboriau-Routhiau, V., Marques, R., Dulauroy, S., Fedoseeva, M., et al. (2015) · Science · doi:10.1126/science.aac4263 · Cited by 863 · see citing works
“2 Materials and Methods Mice Foxp3 mice (43) were crossed to Rorc(γt) mice (15) and maintained on a C57BL/6 background, as were Cd11c x Rosa26 (ΔDC) mice (44), IL-2-deficient (45), IL-10deficient (46), IL-6-deficient (47), Il23a-deficient (48), Nod1/Nod2- and Myd88/Trifdouble deficient mice, Il10 (21) and Gata3 mice (…”
MethodIL-6/IL-6 receptor system and its role in physiological and pathological conditions
Mihara, M., Hashizume, M., Yoshida, H., Suzuki, M., & Shiina, M. (2011) · Clinical Science · doi:10.1042/cs20110340 · Cited by 911 · see citing works
Cooperative Influence of Genetic Polymorphisms on Interleukin 6 Transcriptional Regulation*
Terry, C., Loukaci, V., & Green, F. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000379200 · Cited by 852 · see citing works
IL-6: From its discovery to clinical applications
Kishimoto, T. (2010) · International Immunology · doi:10.1093/intimm/dxq030 · Cited by 846 · see citing works
Self-citationSOCS3 negatively regulates IL-6 signaling in vivo
Croker, B. A., Krebs, D. L., Zhang, J.-G., Wormald, S., Willson, T. A., Stanley, E. G., Robb, L., Greenhalgh, C. J., Förster, I., Clausen, B. E., et al. (2003) · Nature Immunology · doi:10.1038/ni931 · Cited by 840 · see citing works
Hurst, S. M., Wilkinson, T. S., McLoughlin, R. M., Jones, S., Horiuchi, S., Yamamoto, N., Rose-John, S., Fuller, G. M., Topley, N., & Jones, S. A. (2001) · Immunity · doi:10.1016/s1074-7613(01)00151-0 · Cited by 811 · see citing works
Interleukin (IL)-6 directs the differentiation of IL-4-producing CD4+ T cells
Rincón, M., Anguita, J., Nakamura, T., Fikrig, E., & Flavell, R. A. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.3.461 · Cited by 810 · see citing works
“In correlation with the previous characterization of IL-62/2 mice (32, 33), analysis of cellular populations in the spleen”
The molecular details of cytokine signaling via the JAK/STAT pathway
Morris, R., Kershaw, N. J., & Babon, J. J. (2018) · Protein Science · doi:10.1002/pro.3519 · Cited by 865 · see citing works
Uematsu, S., Fujimoto, K., Jang, M. H., Yang, B., Jung, Y.-J., Nishiyama, M., Sato, S., Tsujimura, T., Yamamoto, M., Yokota, Y., et al. (2008) · Nature Immunology · doi:10.1038/ni.1622 · Cited by 746 · see citing works
Interleukin‐6 myokine signaling in skeletal muscle: a double‐edged sword?
Muñoz‐Cánoves, P., Scheele, C., Pedersen, B. K., & Serrano, A. L. (2013) · The FEBS Journal · doi:10.1111/febs.12338 · Cited by 774 · see citing works
Interleukin 6 and its receptor: ten years later
Hirano, T. (1998) · International Reviews of Immunology · doi:10.3109/08830189809042997 · Cited by 788 · see citing works
Antigen-specific memory B cell development.
McHeyzer-Williams, L. J., & McHeyzer-Williams, M. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115732 · Cited by 771 · see citing works
The wolf in sheep's clothing: the role of interleukin-6 in immunity, inflammation and cancer
Naugler, W. E., & Karin, M. (2008) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2007.12.007 · Cited by 730 · see citing works
Interleukin-6 Family CytokinesPreprint
Rose‐John, S. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a028415 · Cited by 801 · see citing works
“In mice fed a high-fat diet, selective blockade of IL-6 trans-signaling prevented the inflammatory infiltration of macrophages into adipose tissue (Kraakman et al. 2015) without leading to increased insulin resistance or decreased glucose tolerance, which had been observed in IL-62/2 mice (Matthews…”
BackgroundCytokines in Sepsis: Potent Immunoregulators and Potential Therapeutic Targets—An Updated View
Schulte, W., Bernhagen, J., & Bucala, R. (2013) · Mediators of Inflammation · doi:10.1155/2013/165974 · Cited by 720 · see citing works
“A key function of IL-6 is the induction of fever [50] and the mediation of the acute phase response [51, 59], a systemic reaction to an inflammatory stimulus that is characterized by fever, leukocytosis, and the release of hepatic acute phase proteins such as C-reactive protein, complement components, fibrinogen, and…”
BackgroundRepression of the Interleukin-6 Promoter by Estrogen Receptor Is Mediated by NF-κB and C/EBPβ
Stein, B., & Yang, M. X. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.9.4971 · Cited by 697 · see citing works
“IL-6 is a multifunctional cytokine that exerts a variety of well-established effects, including B- and T-cell activation, stimulation of fever, and release of acute-phase response proteins (26, 36, 40, 80, 81).”
BackgroundHirota, H., Chen, J., Betz, U. A. K., Rajewsky, K., Gu, Y., Ross, J., Müller, W., & Chien, K. R. (1999) · Cell · doi:10.1016/s0092-8674(00)80729-1 · Cited by 652 · see citing works
“…Biomechanical Stress of the immune system, hepatic function, bone metabolism, neurological function, and hematopoiesis (Stewart et al., 1992; Bernad et al., 1994; Kopf et al., 1994; Poli et al., 1994; Ramsay et al., 1994; Cressman et al., 1996; Romani et al., 1996; Klein et al., 1997; Nandurkar et”
BackgroundIL-6 and APPs: anti-inflammatory and immunosuppressive mediators.
Tilg, H., Dinarello, C., & Mier, J. (1997) · Immunology today (Amsterdam. Regular ed.) · doi:10.1016/s0167-5699(97)01103-1 · Cited by 687 · see citing works
Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling
Jones, S. A., Scheller, J., & Rose‐John, S. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57158 · Cited by 683 · see citing works
“In particular, IL-6–deficient (IL-6KO) mice are viable but show numerous immunological defects (15).”
BackgroundThe soluble interleukin 6 receptor: mechanisms of production and implications in disease
Jones, S. A., Horiuchi, S., Topley, N., Yamamoto, N., & Fuller, G. M. (2001) · The FASEB Journal · doi:10.1096/fj.99-1003rev · Cited by 684 · see citing works
Zenewicz, L. A., Yancopoulos, G. D., Valenzuela, D. M., Murphy, A. J., Karow, M. L., & Flavell, R. A. (2007) · Immunity · doi:10.1016/j.immuni.2007.07.023 · Cited by 628 · see citing works
“IL-6-deficient mice were obtained from The Jackson Laboratories (Bar Harbor, ME) (Kopf et al., 1994).”
MethodVonarbourg, C., Mortha, A., Bui, V. L., Hernández, P. P., Kiss, E. A., Hoyler, T., Flach, M., Bengsch, B., Thimme, R., Hölscher, C., et al. (2010) · Immunity · doi:10.1016/j.immuni.2010.10.017 · Cited by 669 · see citing works
Interleukin-6 stimulates thrombopoiesis through thrombopoietin: role in inflammatory thrombocytosis
Kaser, A., Brandacher, G., Steurer, W., Kaser, S., Offner, F. A., Zoller, H., Theurl, I., Widder, W., Molnar, C., Ludwiczek, O., et al. (2001) · Blood · doi:10.1182/blood.v98.9.2720 · Cited by 667 · see citing works
Teunissen, M., Bos, J. D., Koomen, C. W., Malefyt, R. D. W., & Wierenga, E. (1998) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1998.00347.x · Cited by 648 · see citing works
Interleukin-6: designing specific therapeutics for a complex cytokine
Garbers, C., Heink, S., Korn, T., & Rose-John, S. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.45 · Cited by 643 · see citing works
Charles, P., Elliott, M. J., Davis, D., Potter, A., Kalden, J., Antoni, C., Breedveld, F., Smolen, J., Eberl, G., Dewoody, K., et al. (1999) · Journal of Immunology · doi:10.4049/jimmunol.163.3.1521 · Cited by 614 · see citing works
Role of IL-6 in Asthma and Other Inflammatory Pulmonary Diseases
Rincón, M., & Irvin, C. G. (2012) · International Journal of Biological Sciences · doi:10.7150/ijbs.4874 · Cited by 622 · see citing works
“Using the OVA model and IL-6 deficient mice (35), initial studies indicated that the lack of IL-6 increases eosinophilia, lung Th2 cytokines (IL-4, IL-5 and IL-13) and eotaxin, as well as airway response to methacholine (36).”
MethodInterleukin-6 Signaling and Anti-Interleukin-6 Therapeutics in Cardiovascular Disease
Ridker, P. M., & Rane, M. A. (2021) · Circulation Research · doi:10.1161/circresaha.121.319077 · Cited by 715 · see citing works
Lin, Z.-Q., Kondo, T., Ishida, Y., Takayasu, T., & Mukaida, N. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.0802397 · Cited by 585 · see citing works
“However, IL-6-deficient mice showed an impaired immune response against Listeria monocytogenesis infection and a diminished, inflammatory, acute-phase response after tissue damage or infection [5].”
BackgroundTakeda, K., Kaisho, T., Yoshida, N., Takeda, J., Kishimoto, T., & Akira, S. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.9.4652 · Cited by 584 · see citing works
Self-citationFuster, J. J., Ouchi, N., Gokce, N., & Walsh, K. X. (2016) · Circulation Research · doi:10.1161/circresaha.115.306885 · Cited by 669 · see citing works
Eto, D., Lao, C., Ditoro, D., Barnett, B., Escobar, T. C., Kageyama, R., Yusuf, I., & Crotty, S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017739 · Cited by 569 · see citing works
“Previous studies have characterized the individual roles of IL-21 or IL-6 on B cells and found that IL-21 has a large impact on germinal center development [25,26,35].”
BackgroundMethodCardiac Myocyte Cell Cycle Control in Development, Disease, and Regeneration
Ahuja, P., Sdek, P., & MacLellan, W. R. (2007) · Physiological Reviews · doi:10.1152/physrev.00032.2006 · Cited by 568 · see citing works
Interleukin-6 predicts hypoalbuminemia, hypocholesterolemia, and mortality in hemodialysis patients
Bologa, R. M., Levine, D., Ts, P., Cheigh, J. S., Serur, D. S., Kh, S., & Rubin, A. L. (1998) · American Journal of Kidney Diseases · doi:10.1053/ajkd.1998.v32.pm9669431 · Cited by 551 · see citing works
Shiloh, M. U., MacMicking, J. D., Nicholson, S., Brause, J. E., Potter, S. H., Marino, M., Fang, F. C., Dinauer, M. C., & Nathan, C. (1999) · Immunity · doi:10.1016/s1074-7613(00)80004-7 · Cited by 504 · see citing works
Interleukin-6: discovery of a pleiotropic cytokine
Kishimoto, T. (2006) · Arthritis Research & Therapy · doi:10.1186/ar1916 · Cited by 559 · see citing works
“A study conducted in an IL-6 knockout mouse model [9] revealed that, compared with wild type, the antiviral antibody response was inhibited by more than 90% following immunization with a vesicular stomatitis virus.”
BackgroundSelf-citationInterleukin-6 in the injured patient. Marker of injury or mediator of inflammation?
Biffl, W., Moore, E. E., Moore, F., & Peterson, V. M. (1996) · Annals of Surgery · doi:10.1097/00000658-199611000-00009 · Cited by 558 · see citing works
Pleiotropy and specificity: insights from the interleukin 6 family of cytokines
Murakami, M., Kamimura, D., & Hirano, T. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.027 · Cited by 533 · see citing works
Defective inflammatory response in interleukin 6-deficient mice.
Fattori, E., Cappelletti, M., Costa, P., Sellitto, C., Cantoni, L., Carelli, M., Faggioni, R., Fantuzzi, G., Ghezzi, P., & Poli, V (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.4.1243 · Cited by 525 · see citing works
Targeting IL-6 trans-signalling: past, present and future prospects
Rose-John, S., Jenkins, B. J., Garbers, C., Moll, J. M., & Scheller, J. (2023) · Nature Reviews Immunology · doi:10.1038/s41577-023-00856-y · Cited by 524 · see citing works
“Studies in IL-6-deficient mice showed that IL-6 contributes to the pathogenesis of many inflammatory diseases, including bacterial and viral infections 66 , arthritis 67,68 , experimental colitis 69 and multiple sclerosis 70 .”
Interleukin-6 Signaling Pathway and Its Role in Kidney Disease: An Update
Su, H., Lei, C., & Zhang, C. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00405 · Cited by 525 · see citing works
Signaling role of hemocytes in Drosophila JAK/STAT-dependent response to septic injury.
Agaisse, H., Petersen, U., Boutros, M., Mathey-Prevot, B., & Perrimon, N. (2003) · Developmental Cell · doi:10.1016/s1534-5807(03)00244-2 · Cited by 498 · see citing works
“response (Fattori et al., 1994; Kopf et al., 1994).”
The Role of Interleukin 6 During Viral Infections
Velázquez-Salinas, L., Verdugo-Rodríguez, A., Rodriguez, L. L., & Borca, M. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.01057 · Cited by 488 · see citing works
Development and Selection of T Cells: Facts and Puzzles
Kisielow, P., & von Boehmer, H. (1995) · Advances in immunology · doi:10.1016/s0065-2776(08)60620-3 · Cited by 432 · see citing works
Samoilova, E. B., Horton, J. L., Hilliard, B. A., Liu, T.-S. T., & Chen, Y. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.12.6480 · Cited by 441 · see citing works
“Our observation that polyclonal T cell activation is normal in IL-6-deficient mice confirms earlier reports that immune response to mitogens in IL-6-deficient mice is comparable to that of normal mice (19, 20).”
BackgroundMethodResultInfluentialSack, G. H. (2018) · Molecular Medicine · doi:10.1186/s10020-018-0047-0 · Cited by 507 · see citing works
“Mice deficient in IL-6 can produce at least a partial APR, depending on the stimulus (Kopf et al. 1994).”
BackgroundTebbutt, N. C., Giraud, A. S., Inglese, M., Jenkins, B., Waring, P., Clay, F. J., Malki, S., Alderman, B. M., Grail, D., Hollande, F., et al. (2002) · Nature Medicine · doi:10.1038/nm763 · Cited by 474 · see citing works
“We detected no gastric hyperplasia in age-matched gp130 ΔSTAT , IL-6 −/− (ref”
BackgroundThe role of interleukin-6 in mucosal IgA antibody responses in vivo
Ramsay, A. J., Husband, A. J., Ramshaw, L. A., Bao, S., Matthaei, K. I., Koehler, G., & Kopf, M. (1994) · Science · doi:10.1126/science.8160012 · Cited by 454 · see citing works
Self-citationImpaired cutaneous wound healing in interleukin‐6‐deficient and immunosuppressed mice
Gallucci, R. M., Simeonova, P. P., Matheson, J. M., Kommineni, C., Guriel, J. L., Sugawara, T., & Luster, M. I. (2000) · The FASEB Journal · doi:10.1096/fj.00-0073com · Cited by 402 · see citing works
Marrack, P., & Kappler, J. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104554 · Cited by 439 · see citing works
Inhibition of Th1 Differentiation by IL-6 Is Mediated by SOCS1
Diehl, S. A., Anguíta, J., Hoffmeyer, A., Zapton, T., Ihle, J. N., Fikrig, E., & Rincón, M. (2000) · Immunity · doi:10.1016/s1074-7613(00)00078-9 · Cited by 402 · see citing works
The Immunobiology of the Interleukin-12 Family: Room for Discovery
Wojno, E. D. T., Hunter, C. A., & Stumhofer, J. S. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.011 · Cited by 485 · see citing works
“The generation of mice deficient in IL-6 affirmed its important role as an acute phase reactant and in innate resistance to bacterial challenges (Kopf et al., 1994).”
Camargo, C. A., Madden, J. F., Gao, W., Selvan, R. S., & Clavien, P. (1997) · Hepatology · doi:10.1002/hep.510260619 · Cited by 420 · see citing works
NF-kappa B and rel proteins in innate immunity.
Kopp, E., & Ghosh, S. (1995) · Advances in Immunology · doi:10.1016/s0065-2776(08)60618-5 · Cited by 426 · see citing works
The role of IL-6 in host defence against infections: immunobiology and clinical implications
Rose-John, S., Winthrop, K., & Calabrese, L. (2017) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2017.83 · Cited by 424 · see citing works
Oncogenic Ras-induced secretion of IL6 is required for tumorigenesis
Ancrile, B., Lim, K.-H., & Counter, C. M. (2007) · Genes & Development · doi:10.1101/gad.1549407 · Cited by 422 · see citing works
“129S2-IL6tm1Kopf/J) (Kopf et al. 1994) (Jackson Laboratory) were shaved, and the following day, 150 µL of 125 µg/mL DMBA (Sigma) in DMSO were applied topically, followed 1 wk later by twice-weekly topical applications of 150 µL of 10−4 M TPA (Sigma) in DMSO for 20 wk.”
MethodInterleukin 6 plays a key role in the development of antigen-induced arthritis
Ohshima, S., Saeki, Y., Mima, T., Sasai, M., Nishioka, K., Nomura, S., Kopf, M., Katada, Y., Tanaka, T., Suemura, M., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.8222 · Cited by 406 · see citing works
Self-citationZheng, H., Fletcher, D., Kozak, W., Jiang, M., Hofmann, K. J., Corn, C., Soszynski, D., Grabiec, C., Trumbauer, M., Shaw, A. R., et al. (1995) · Immunity · doi:10.1016/1074-7613(95)90154-x · Cited by 404 · see citing works
Tofaris, G., Patterson, P., Jessen, K., & Mirsky, R. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-15-06696.2002 · Cited by 403 · see citing works
“The IL -6 knock-out strain (il-6/) was produced by Kopf et al. (1994) and was purchased from The Jackson Laboratory (Bar Harbor, M A.) Sciatic nerves were excised from wild-type, lif/, il- 6/, as well as LI F/ IL -6 double knock-out (lif/il-6/) mice.”
MethodGlucocorticoids and immune function: unknown dimensions and new frontiers.
Wilckens, T., & de Rijk, R. (1997) · Immunology today (Amsterdam. Regular ed.) · doi:10.1016/s0167-5699(97)01111-0 · Cited by 400 · see citing works
Aliyu, M., Zohora, F. T., Anka, A. U., Ali, K., Maleknia, S., Saffarioun, M., & Azizi, G. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109130 · Cited by 433 · see citing works
Dechiara, T., Vejsada, R., Poueymirou, W., Acheson, A., Suri, C., Conover, J., Friedman, B., Mcclain, J., Pan, L., Stahl, N., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90172-8 · Cited by 395 · see citing works
New Insights into the Biology of the Acute Phase Response
Suffredini, A., Fantuzzi, G., Badolato, R., Oppenheim, J., & O'Grady, N. (1999) · Journal of Clinical Immunology · doi:10.1023/a:1020563913045 · Cited by 393 · see citing works
“A critical role for IL-6 in the acute phase response is seen in the IL-6 knockout mouse, which has significant depression of acute phase protein release compared to normal mice in response to sterile inflammation with turpentine and intracellular Gram-positive infection, and less so with LPS (12).”
BackgroundMedium-chain Fatty Acids as Ligands for Orphan G Protein-coupled Receptor GPR84*
Wang, J.-H., Wu, X.-S., Simonavicius, N., Tian, H., & Ling, L. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m608019200 · Cited by 391 · see citing works
Interleukin‐6: Structure‐function relationships
Simpson, R. J., Hammacher, A., Smith, D. K., Matthews, J., & Ward, L. D. (1997) · Protein Science · doi:10.1002/pro.5560060501 · Cited by 388 · see citing works
- Authors
- Kopf, M., Baumann, H., Freer, G., Freudenberg, M., Lamers, M., Kishimoto, T., Zinkernagel, R., Bluethmann, H., & Köhler, G.
- Affiliations
- University of Zurich (CH)
- Max Planck Society (DE)
- The University of Osaka (JP)
- F. Hoffmann-La Roche AG (CH)
- Roswell Park Comprehensive Cancer Center (US)
- Venue
- Nature
- Published
- 1994-03-24
- Volume
- 368
- Issue
- 6469
- Pages
- 339-342
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2067761476
- Cited by
- 1,768
- References
- 0
- Citations by year
- 2026: 20 · 2025: 33 · 2024: 23 · 2023: 36 · 2022: 44 · 2021: 58 · 2020: 43 · 2019: 52 · 2018: 46 · 2017: 60 · 2016: 57 · 2015: 44 · 2014: 48 · 2013: 56 · 2012: 64
- FWCI
- 28.71
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- CINECA IRIS Institutial research information system (University of Pisa) (submittedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cytokine Signaling Pathways and Interactions
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- interleukin-6, IL-6-deficient mice, gene disruption, acute phase response, immune response, vaccinia virus infection, Listeria monocytogenes, T cell-dependent antibody response, vesicular stomatitis virus, lipopolysaccharide, gp130, cytokine redundancy, inflammation, macrophages, liver
- MeSH terms
- Acute-Phase Reaction, Animals, B-Lymphocytes, Immunity, Listeriosis, Lymphoid Tissue, Mice, Inbred C57BL, RNA, Messenger, T-Lymphocytes, Vesicular stomatitis Indiana virus, Interleukin-6, Rhabdoviridae Infections, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
